Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Impact of Symptom Clusters on Quality of Life Outcomes in Patients from Japan with Advanced Nonsmall Cell Lung Cancers.

Hamada T, Komatsu H, Rosenzweig MQ, Chohnabayashi N, Nishimura N, Oizumi S, Ren D.

Asia Pac J Oncol Nurs. 2016 Oct-Dec;3(4):370-381. doi: 10.4103/2347-5625.196489.

2.

Expression of Notch1 and Numb in small cell lung cancer.

Kikuchi H, Sakakibara-Konishi J, Furuta M, Yokouchi H, Nishihara H, Yamazaki S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Harada T, Higuchi M, Honjo O, Minami Y, Watanabe N, Oizumi S, Suzuki H, Ishida T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M.

Oncotarget. 2017 Feb 7;8(6):10348-10358. doi: 10.18632/oncotarget.14411.

3.

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.

Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Goto A, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M.

Oncotarget. 2016 Dec 31. doi: 10.18632/oncotarget.14410. [Epub ahead of print]

4.

The predictive value of endobronchial ultrasonography with a guide sheath in the diagnosis of the histologic subtypes of lung cancer.

Takeuchi Y, Shinagawa N, Kikuchi E, Matsuno Y, Hida Y, Kaga K, Oizumi S, Nishimura M.

Respir Investig. 2016 Nov;54(6):473-478. doi: 10.1016/j.resinv.2016.05.003. Epub 2016 Jul 1.

PMID:
27886860
5.

Usefulness of Endobronchial Ultrasonography With a Guide Sheath and Virtual Bronchoscopic Navigation for Ground-Glass Opacity Lesions.

Ikezawa Y, Shinagawa N, Sukoh N, Morimoto M, Kikuchi H, Watanabe M, Nakano K, Oizumi S, Nishimura M.

Ann Thorac Surg. 2017 Feb;103(2):470-475. doi: 10.1016/j.athoracsur.2016.09.001. Epub 2016 Nov 5.

PMID:
27825686
6.

Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.

Sakakibara-Konishi J, Ikezawa Y, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M.

Int J Clin Oncol. 2017 Apr;22(2):257-268. doi: 10.1007/s10147-016-1060-3. Epub 2016 Nov 5.

PMID:
27816990
7.

Proton-switchable vapochromic behaviour of a platinum(ii)-carboxy-terpyridine complex.

Kobayashi A, Oizumi S, Shigeta Y, Yoshida M, Kato M.

Dalton Trans. 2016 Nov 1;45(43):17485-17494.

PMID:
27739547
8.

Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer.

Ikezawa Y, Sakakibara-Konishi J, Mizugaki H, Oizumi S, Nishimura M.

Int J Clin Oncol. 2017 Feb;22(1):59-69. doi: 10.1007/s10147-016-1031-8. Epub 2016 Aug 23.

PMID:
27553958
9.

Bactericidal Action of Photo-Irradiated Aqueous Extracts from the Residue of Crushed Grapes from Winemaking.

Tsukada M, Sheng H, Tada M, Mokudai T, Oizumi S, Kamachi T, Niwano Y.

Biocontrol Sci. 2016;21(2):113-21. doi: 10.4265/bio.21.113.

10.

Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.

Kitai H, Ebi H, Tomida S, Floros KV, Kotani H, Adachi Y, Oizumi S, Nishimura M, Faber AC, Yano S.

Cancer Discov. 2016 Jul;6(7):754-69. doi: 10.1158/2159-8290.CD-15-1377. Epub 2016 May 6.

PMID:
27154822
11.

Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.

Takashina T, Kinoshita I, Kikuchi J, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Nishimura M, Dosaka-Akita H.

Cancer Sci. 2016 Jul;107(7):955-62. doi: 10.1111/cas.12957. Epub 2016 Jun 13.

12.

Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.

Naka T, Hatanaka Y, Marukawa K, Okada H, Hatanaka KC, Sakakibara-Konishi J, Oizumi S, Hida Y, Kaga K, Mitsuhashi T, Matsuno Y.

Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0.

13.

Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).

Yokouchi H, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Fukuhara T, Takamura K, Kojima T, Harada T, Higuchi M, Matsuura Y, Honjo O, Minami Y, Watanabe N, Nishihara H, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M.

Lung Cancer. 2015 Dec;90(3):548-53. doi: 10.1016/j.lungcan.2015.10.010. Epub 2015 Oct 14.

PMID:
26604032
14.

Correction: Cytoprotective Effects of Grape Seed Extract on Human Gingival Fibroblasts in Relation to Its Antioxidant Potential.

Katsuda Y, Niwano Y, Nakashima T, Mokudai T, Nakamura K, Oizumi S, Kanno T, Kanetaka H, Egusa H.

PLoS One. 2015 Sep 14;10(9):e0138394. doi: 10.1371/journal.pone.0138394. eCollection 2015. No abstract available.

15.

Cytoprotective effects of grape seed extract on human gingival fibroblasts in relation to its antioxidant potential.

Katsuda Y, Niwano Y, Nakashima T, Mokudai T, Nakamura K, Oizumi S, Kanno T, Kanetaka H, Egusa H.

PLoS One. 2015 Aug 10;10(8):e0134704. doi: 10.1371/journal.pone.0134704. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138394.

16.

Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.

Inoue A, Sugawara S, Maemondo M, Mori Y, Oizumi S, Harada M, Taima K, Morikawa N, Ishida T, Kinoshita I, Watanabe H, Suzuki T, Nakagawa T, Saito R, Nukiwa T.

Lung Cancer. 2015 Jul;89(1):61-5. doi: 10.1016/j.lungcan.2015.04.012. Epub 2015 May 4.

PMID:
26004087
17.

Virtual bronchoscopic navigation improves the diagnostic yield of radial-endobronchial ultrasound for peripheral pulmonary lesions with involved bronchi on CT.

Asano F, Shinagawa N, Ishida T, Tsuzuku A, Tachihara M, Kanazawa K, Yamada N, Oizumi S, Moriya H.

Intern Med. 2015;54(9):1021-5. doi: 10.2169/internalmedicine.54.3497. Epub 2015 May 1.

18.

Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

Miyauchi E, Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T; North-East Japan Study Group..

Jpn J Clin Oncol. 2015 Jul;45(7):670-6. doi: 10.1093/jjco/hyv054. Epub 2015 Apr 15.

PMID:
25877748
19.

Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation.

Fukuhara T, Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Saijo Y, Hagiwara K, Morita S, Nukiwa T.

Lung Cancer. 2015 May;88(2):181-6. doi: 10.1016/j.lungcan.2015.02.004. Epub 2015 Feb 9.

20.

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.

Sugawara S, Oizumi S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Yoshizawa H, Ito K, Gemma A, Nishitsuji M, Harada M, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Kurihara M, Nukiwa T; North East Japan Study Group and Tokyo Cooperative Oncology Group..

Ann Oncol. 2015 May;26(5):888-94. doi: 10.1093/annonc/mdv063. Epub 2015 Feb 10.

PMID:
25669832

Supplemental Content

Loading ...
Support Center